Harvard Medical School – Telltale Tau Protein & Alzheimer’s Early Diagnosis & Treatment

Harvard Medical School – Telltale Tau  (Full Article)

Researchers at Harvard Medical School & Beth Israel Deaconess Medical Center have together found that the Tau protein, ” hard-working participant in memory and normal brain functioning,” can now be used to detect early diagnosis and treatment of alzheimer’s disease.

The tau protein is suspected to have 2 forms one healthy and the other diseased. The disease prone is found in the neurons of early stage alzheimer’s patients. The researchers are hoping this is will be a significant step in the treatment b targeting these unhealthy tau protein cells. Through the development of new antibodies and vaccines, researchers are hopeful that such new treatment may be effective in the treatment and even prevention of acute alzheimer’s symptoms from manifestation in its earliest stage.

Established in September 1782, Harvard University Medical School’s  mission is to, “To create and nurture a diverse community of the best people committed in the leadership in alleviating human suffering caused by disease.” Consistently ranked in amongst the top medical research programs in America, its core commitment values are: innovation in education;  science discovery & integrity; diversity & professional development; and service to humanity.